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OBJECTIVES: The aim of this study was to determine the reli-
ability and validity of the Fatigue Symptom Inventory (FSI) for
the Turkish population. METHODS: The research was con-
ducted in the university students. The study sample included 200
student, (56% women, 44% men) Data were collected with a
sociodemographic form, FSI, SF-36. The original instrument was
translated and back translated by two independent translators.
For psychometric measures, a small sample was used to check the
initial comprehension and factibility. Cronbach’s Alfa was used
to assess reliability and factor analysis to assess dimensionality.
The SF 36 were used for concurrent validity. RESULTS: The
internal consistency coefﬁcient (Cronbach’s alpha) of FSI was
0.91. Factor analysis of the scale revealed that it was composed
of 3 factors with Eigenvalues >1.0, accounting for 65.4% of the
total variance. All items of the Turkish FSI had a factor load
ranging from 0.286 to 0.820 and they all belonged to 3 factors.
There was a strong relationship between FSI, and SF 36
(r = between 0.651–0.759). CONCLUSIONS: The research sug-
gests that the validity and reliability of the Turkish FSI are
satisfactory, and that it can be used in Turkey.
PIH19
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OBJECTIVES:The link between obesity or being overweight with
life-threatening illnesses is well established. Furthermore, health-
related quality of life (HRQoL) is reduced when body mass index
(BMI) is elevated, but there are limited data on the effects of BMI
on HRQoL in the general population or the aspects of HRQoL
that are most affected. The objective of this study was to investi-
gate the relationship between BMI and HRQoL, and any differ-
ences between men and women using data from the 2003 Health
Survey of England. METHODS: HRQoL (derived from EQ-5D
responses) data from the 2003 Health Survey of England was
used. Responses from 14,836 individuals were utilised, and
univariate regression and linear regression analyses, controlling
for confounding factors such as obesity related co-morbidities,
were conducted to examine the relationship between BMI and
HRQoL. RESULTS: A signiﬁcant association between BMI and
HRQoLwas found after controlling for gender, age, age when left
school, manual work, and ﬁve obesity-related morbidities. The
maximum HRQoL was reached at a BMI of 26.0 in males and at
a BMI of 24.4 in females, which means that BMI is negatively
associatedwithHRQoL for both underweight and obese individu-
als. At higher BMI values, men reported higher HRQoL than
women, suggesting that obesity and being overweight has a
greater impact on HRQoL for females than for males. At lower
BMI values, HRQoL was lower in men than women. In women,
all ﬁve dimensions of the EQ-5D (mobility, self-care, usual activity,
pain and anxiety) worsened with obesity—in men, all but anxiety
were worsened. CONCLUSIONS: There is a signiﬁcant associa-
tion between BMI andHRQoL inmales and females in the general
population.Nearly all aspects ofHRQoL are adversely affected by
elevated BMI. The optimum HRQoL is achieved with a BMI of
approximately 25 for both males and females.
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OBJECTIVES: Obesity is a growing problem for children, yet
little is known about the impact of weight on acute injury.
Determine relationships between weight and morbidity/family
disruption for children treated and discharged home from PED
for minor injuries (soft tissue injuries, lacerations, sprains,
strains, and minor head injury). DESIGN/METHODS: Prospec-
tive pilot study of children treated and discharged to home.
Families completed questionnaire and interview in PED and at
1-week telephone follow-up. Patients divided into two groups: 1)
healthy weight (HW; BMI >5th <85th percentile), or 2) overweight
(O; BMI 85th <95th percentile) combined with obese (Ob; BMI
95th percentile). RESULTS: Thirty-ﬁve families completed
follow-up. Mean patient age = 8.33 years; weight ranged from
28.6 – 207.5 pounds (M = 86.9, SD = 53.0). Consistent with
previous reports, O/Ob children accounted for 4 of 5 fractures.
At baseline, increased weight was signiﬁcantly correlated with
parent reports of decreased HRQOL (Pediatric Quality of
Life Inventory) across all domains: Total (rs = -0.553, p =
0.001), Physical Summary (rs = -0.473, p < 0.005), Psychosocial
Summary (rs = -0.541, p = 0.001), Social (rs = -0.481,
p < 0.005), and School (rs = -0.554, p < 0.005), with the excep-
tion of Emotional. Increased weight was signiﬁcantly correlated
with increased number of post-injury days identiﬁed by parents
as abnormal (rs = 0.433, p < 0.005). ED physicians were more
likely (phi = 0.655) to recommend a follow-up visit for patients
identiﬁed as O/Ob than HW, despite similar injury type and body
part affected. However, parents of O/Ob children were more
likely (phi = 0.454) to report that their family was “back to
normal” at 1-week follow-up. CONCLUSIONS: Increased
weight was correlated with decreased QOL at baseline, and
greater morbidity and family disruption for pediatric patients
with acute injuries treated in the ED. Future research is needed to
further explore these ﬁndings.
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OBJECTIVES: In France, some 10 million women are undergo-
ing the menopause, while 300,000 to 500,000 become meno-
pausal every year. Climacteric disorders, of variable intensity
and frequency, can be found in more than 50% of them. Upon
occurrence of the menopause, 30 to 50% of women also com-
plain of non-speciﬁc disorders (sleep difﬁculties or mood swings,
symptoms of depression, etc.), which the same as hot ﬂushes, can
be highly debilitating and alter the quality of life of the patient
and those around her, in her private and professional life. The
authors have assessed patient satisfaction with regard to treat-
ment of these disorders with 2 daily capsules of Soy+Mag, or one
daily 37.5 mg dose of soy isoﬂavones in the form of aglycone.
METHODS: 78 menopausal patients complaining spontane-
ously of hot ﬂushes during a medical consultation were included
in this pragmatic study, carried out under real-life conditions.
The study protocol consisted of assessing changes in patients’
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functional symptomatology and quality of life. This involved
self-questionnaires, which included the Menopause Rating Scale
(MRS), the Epworth scale, the Short Form 12 (SF12) and the
Centre for Epidemiologic Studies Depression Scale (CES-D),
being ﬁlled out at D0 by the investigator, the patient and her
spouse, then at D56 by the patient and her spouse only.
RESULTS: Upon inclusion, the average age of patients was 54.8
years, with an average BMI of 24.1. Their most recent menstrua-
tions were an average of 4.1 years ago, and they complained of
hot ﬂushes, joint pain and sleep difﬁculties. After 56 days of
treatment with Soy+Mag, a statistically signiﬁcant decrease in
hot ﬂushes was observed (the most frequently found symptom
upon inclusion), along with a statistically signiﬁcant improve-
ment in global, somatic and psychological symptomatology
linked to menopause, and a statistically signiﬁcant improvement
in the patients’ quality of life from a psychological standpoint.
These complaints and their improvement were also clearly iden-
tiﬁed by the investigator and the spouse, though with a differing
intensity that could explain the lack of improvement in quality of
life of the spouse, despite the beneﬁts perceived by his wife.
CONCLUSIONS: The interest in Soy+Mag in treating the func-
tional symptoms of menopausal patients is conﬁrmed by the
statistically signiﬁcant improvement in hot ﬂushes and psycho-
logical symptoms. This study has shown that treatment of the
functional and psychological symptoms of menopausal patients
can be noticeably improved by using soy isoﬂavones.
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OBJECTIVES: Assisted reproductive technologies (ART) are fre-
quently targeted for budget cuts and rationing because infertility
is often considered a low priority. Treatments options are varied
where in-vitro fertilization (IVF) and intracytoplasmic sperm
injection (ICSI) are some of the more interventional and expen-
sive methods. In 2003, in an effort to control expenditure, the
German health authorities decreased funding for ART which
increased costs faced by consumers for IVF and ICSI from €0 to
€1500 and €2000 per cycle, respectively. Based on increased costs
to consumers we estimated the price-elasticity of demand for
fertility services in Germany. METHODS: IVF and ICSI cycle
data was obtained from the Deutsches IVF Register ﬁve years
prior, and one year following implementation of the funding
change. Because demand surged in the year prior to the new
policy, demand was based on the average ﬁve-year change in
cycles as well as the demand one year prior to funding cuts. The
arc-price elasticity of demand method was used to derive elas-
ticities. The cross-price elasticity of clomifene was also evaluated
to assess whether substitution with this low cost treatment
occurred resulting from increased IVF and ICSI costs. RESULTS:
The average annual growth rate for IVF and ICSI cycles during
the ﬁve-year period prior to the policy change was 8% and 30%,
respectively. Growth rates the year prior to the policy change
were 17% and 36% for IVF and ICSI, respectively. Based on the
averaged ﬁve-year change prior to the policy change we estimate
price-elasticities one year after the policy for IVF and ICSI of
0.38 and 0.09, respectively. The price elasticity based on 1-year
change in demand for IVF and ICSI was 0.41 and 0.34, respec-
tively. The cross-price elasticity for clomifene was 0.01 suggest-
ing demand was independent of IVF and ICSI. CONCLUSIONS:
The price elasticity ratios suggest demand for IVF and ICSI in
Germany is relatively inelastic i.e., demand is not associated
closely with price changes. This ﬁnding may be regarded as
contrary to the 50% reduction in IVF/ICSI cycles observed sug-
gesting demand is price sensitive. This can be explained by a
much larger percentage increase in price than the percentage
reduction in services demanded. If demand for IVF/ICSI were
elastic (i.e., elasticity >1.0) the reduction in cycles would have
been much larger. The near zero cross-price elasticity for clo-
mifene suggests demand is independent of IVF/ICSI. These ﬁnd-
ings can help policy makers estimate the consequences of
increasing patient co-payments for ART in the future.
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OBJECTIVES: Polypharmacy in elderly patients has grown in
the last decade giving place to new therapeutic and economic
challenges. The aim of this study was to characterize the nature
of polypharmacy and to identify associated direct drug costs.
METHODS: A community pharmacy based cross-sectional
study was carried out using the brown-bag review methodology.
Elderly patients (65 years old) currently taking 4 or more
drugs were invited to participate in the study. Drugs were clas-
siﬁed using ATC codes and costs were identiﬁed as the retail
prices. SAS Guide version 4.0 was used for statistical analysis,
95% conﬁdence intervals for the average costs per patient and
Mann-Whitney Wilcoxon test to identify differences between
expenditure patterns were used. RESULTS: A total of 1597
patients (66% women, mean age 74.5  6.4 years) were
recruited in 158 pharmacies. Average medicines consumption
was found to be 7.6 per patient. Mean daily cost per patient was
€3.2 (CI 95%: 3.1–3.3). Differences in costs according to age,
gender, educational level or residential area were not statistically
signiﬁcant. Sinvastatin, omeprazol and clopidogrel were identi-
ﬁed as the most costly drugs. CONCLUSIONS: Polypharmacy
was found to be highly prevalente amongst Portuguese elderly
population. Associated direct daily drug costs in these patients
were found to be three times higher when compared to the
general population.
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ASSESSMENT OF CURRENT CLINICAL PRACTICE AMONG
PHYSICIANS AND SEXTHERAPISTS REGARDING ERECTILE
DYSFUNCTION (ED)TREATMENT INITIATION WITH
PHOSPHODIESTERASE-5 INHIBITORS (PDE5I)
Schnetzler G1, Marfatia A2, Symonds T3, Chambers R2, Muniain J4
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OBJECTIVES: The aim of this study was to assess the self-
reported clinical practice of physicians, when assessing a patient
presenting with ED for the ﬁrst time and to understand physi-
cian’s and sex therapist’s views on current ED management.
METHODS: The study was conducted during the 2008 annual
congress of the European Association of Urology (EAU). Del-
egates visiting the Pﬁzer exhibition booth were requested to
complete an electronic survey consisting of six closed questions.
Respondents, who were physicians/sex therapists, were selected
for analysis. In addition to demographics, the questions
addressed average frequency of seeing new ED patients/month,
iterative actions taken when an ED patient presented for the ﬁrst
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